loading...

Angioedema Activity Score (AAS)

Weller K; Groffik A; Magerl M; Tohme N; Martus P; Krause K; Metz M; Staubach P; Maurer M

ProQolid

Basic description

Developed in 2013

Daily diary using a combination of symptom severity and frequency items

Authors

Weller K; Groffik A; Magerl M; Tohme N; Martus P; Krause K; Metz M; Staubach P; Maurer M

Copyright
MOXIE Company
Objective
To measure disease activity in patients with recurrent angioedema
Therapeutic area
  • Cardiovascular Diseases
  • Skin and Connective Tissue Diseases
  • Immune System Diseases
  • Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Therapeutic indication

Angioedemas, Hereditary

Chronic spontaneous urticaria (csU)
Hereditary angioedema (HAE1&2)
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • German for Germany
Translations
21 translation(s)
Bibliographic reference(s) of the original questionnaire

Weller K, Groffik A, Magerl M, et al. Development, validation, and initial results of the Angioedema Activity Score. Allergy. 2013 Sep;68(9):1185-92 (Full Text Article)

Member Access

Subscribe to PROQOLID to access to full informations

And get access to advanced descriptions of Clinical Outcome Assessments (COAs)!

A question? Contact us